Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Astrazeneca plc crawled date : 2022 - 06 - 27 save search
Cancer Immunotherapy Market Expands with Rising Adoption of Target Therapy in Cancer Treatment, States TMR Report
Published: 2022-06-27 (Crawled : 16:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: 0.47%
H: 3.73%
C: 3.73%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 4.15%
H: 0.0%
C: 0.0%
AZNCF | $138.24 -1.36% -4.19% 800
|
Health Technology
|
| O: -1.55%
H: 4.43%
C: 0.03%
PFE A | $25.39 -0.12% 0.24% 31M
|
Health Technology
|
| O: 1.46%
H: 1.45%
C: 0.78%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 1.86%
H: 1.05%
C: 0.24%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: -0.16%
H: 0.61%
C: 0.18%
LLY | $745.95 -0.64% -0.13% 17K
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: 0.0%
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: 0.34%
H: 1.72%
C: 0.95%
SPPI | $1.03 -0.97% 0
|
Health Technology
|
| O: 0.0%
H: 2.28%
C: -2.27%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 0.53%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 3.6M
|
Health Technology
|
| O: -0.36%
H: 1.22%
C: 0.38%
immunotherapy report therapy cancer market treatment
Cancer Gene Therapy Market to Grow at 10.1% through 2032, Amid High Adoption in Breast Cancer Treatment - Future Market Insights, Inc.
Published: 2022-06-27 (Crawled : 15:20) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: 0.47%
H: 3.73%
C: 3.73%
AZNCF | $138.24 -1.36% -4.19% 800
|
Health Technology
|
| O: -1.55%
H: 4.43%
C: 0.03%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 1.86%
H: 1.05%
C: 0.24%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: -0.16%
H: 0.61%
C: 0.18%
CRNX | $43.01 -2.27% -2.34% 400K
|
Health Technology
|
| O: 0.66%
H: 1.22%
C: -5.83%
AZN | $68.36 -0.25% -0.25% 3.6M
|
Health Technology
|
| O: -0.36%
H: 1.22%
C: 0.38%
AMGN | $262.75 -0.5% -0.49% 1.4M
|
Health Technology
|
| O: -0.08%
H: 0.45%
C: -0.13%
ADAP | $0.8984 -8.98% -9.86% 48K
|
Health Technology
|
| O: 1.85%
H: 6.67%
C: 3.03%
treatment therapy cancer market
Valued to be $12.9 Billion by 2026, Crohn`s Disease (CD) Therapy Slated for Robust Growth Worldwide
Published: 2022-06-27 (Crawled : 12:20) - prnewswire.com
AZNCF | $138.24 -1.36% -4.19% 800
|
Health Technology
|
| O: -1.55%
H: 4.43%
C: 0.03%
PFE A | $25.39 -0.12% 0.24% 31M
|
Health Technology
|
| O: 1.46%
H: 1.45%
C: 0.78%
NVO | $122.75 -1.43% 0.65% 2.7M
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 1.86%
H: 1.05%
C: 0.24%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.78%
H: 0.94%
C: 0.26%
CCXI | $51.99 -0.04%
|
Health Technology
|
| O: -4.88%
H: 1.04%
C: -1.25%
AZN | $68.36 -0.25% -0.25% 3.6M
|
Health Technology
|
| O: -0.36%
H: 1.22%
C: 0.38%
disease therapy growth
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
ZCMD | $1.45 5.84% 49.63% 15M
|
Commercial Services
AULT | $0.2421 -7.7% 45.23% 16M
|
Manufacturing
TPET | $0.3279 -3.56% 28.48% 33M
|
n/a
TIRX | $0.8 65.02% 25.95% 410K
|
VTNR 4 | $1.31 33.78% 25.82% 220K
|
Industrial Services
GDHG | $0.263 21.76% 25.34% 1.3M
|
HOLO | $2.95 31.7% 22.49% 37M
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
UMAC | $1.55 0.65% 12.9% 0
|
TAOP | $1.08 13.01% 11.51% 19K
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.